Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

LSP Leads €21m Series B Round of Neurent Medical (2021-01-20)
LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in Neurent Medical, an Irish medical device company pioneering innovative treatments for chronic inflammatory diseases of the sinuses and nasal passages. The €21 mil...
CoviCept Receives $2.3m Seed Investment from Forbion (2021-01-19)
Proceeds used to develop small molecule inhibitor of SARS-CoV-2 and other RNA viruses Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed investment in newly formed CoviCept Therapeutics, Inc. (“CoviCept”), a California...
Thermo Acquires Viral Vector Business from Novasep for €725m (2021-01-15)
Expanded global capacity addresses growing demand for cell and gene therapy Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences...
NewAmsterdam Pharma Completes €160m Series A Round (2021-01-14)
> Founding investor Forbion joined by co-lead investors, Morningside Ventures and Ascendant BioCapital, and other leaders in global biopharmaceutical investment > Funding will support initiation and finalization of Phase 3 development of obicetrapib, a potent A...
Novartis Licenses Tislelizumab from BeiGene, $650m Upfront (2021-01-11)
> Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and long-term growth > Novartis secures development and commercialization rights in North America, Europe, and Japan...
Affimed: up to $25m in Term Loans from SVB (2021-01-11)
€10 million available at closing and up to €15 million available upon achievement of certain milestones Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announce...
Qiagen Appoints Toralf Haag as Supervisory Board Member (2021-01-08)
Dr. Toralf Haag appointed to Supervisory Board and a member of the Audit Committee QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect. He will also ...
Qiagen to Distribute Sanger Institute’s COSMIC Database (2021-01-07)
> Exclusive sales, marketing, support and distribution by QIAGEN > Including over 71 million cancer mutations, the COSMIC Database joins QIAGENs’ portfolio for cancer genomic analysis and interpretation > Agreement effective from January 1, 2021 QIAGEN a...
Bayer to Support CureVac with Regard to COVID-19 Vaccine (2021-01-07)
> Companies enter into a collaboration and services agreement > Bayer to support CureVac in numerous areas, including development and supply of CVnCoV > CureVac benefits from Bayer´s expertise and established infrastructure > Plan to facilitate the supply ...
BioGeneration Ventures BGV IV Fund Closes at €140m (2021-01-07)
> BGV now one of the largest biotech investors in early stage ventures and company creation in Europe > BGV IV includes new investors Eli Lilly and Company and Novo Holdings, joining existing investors Bristol Myers Squibb, European Investment Fund, Industriens ...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)